Skip to main content

Showing 2 matches for the following: Inventor: "Gooden, David" ×

The use of arylcyclopropylamine inhibitors in the treatment of Parkinson’s disease

The use of arylcyclopropylamine inhibitors in the treatment of Parkinson’s disease

Value Proposition Treatment options for Parkinson’s disease are currently quite limited, and generally involve dopamine replacement therapy with a variety of dopaminergic agents. Levodopa (L-DOPA), the immediate precursor to dopamine, is currently the gold standard…

Read More

Novel small molecule mast cell activator vaccine adjuvants

Novel small molecule mast cell activator vaccine adjuvants

Value Proposition Mast cells (MCs) are innate immune cells highly prevalent in the dermal region of the skin and in the respiratory, gastrointestinal, and urinary tract mucosa. The strategic location at the host–environment interface and…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us